.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,545,750

« Back to Dashboard

Details for Patent: 5,545,750

Title: Retroviral protease inhibiting compounds
Abstract:A retroviral protease inhibiting compound of the formula or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group; A is (1) substituted amino, (2) substituted carbonyl, (3) functionalized imino, (4) functionalized alkyl, (5) functionalized acyl, (6) functionalized heterocyclic or (7) functionalized (heterocyclic)alkyl; and B is (1) substituted carbonyl independently defined as herein, (2) substituted amino independently defined as herein, (3) functionalized imino independently defined as herein, (4) functionalized alkyl independently defined as herein, (5) functionalized acyl independently defined as herein, (6) functionalized heterocyclic independently defined as herein or (7) functionalized (heterocyclic)alkyl independently defined as herein.
Inventor(s): Kempf; Dale J. (Lake Villa, IL), Norbeck; Daniel W. (Lindenhurst, IL), Erickson; John W. (Barrington, IL), Sham; Hing Leung (Gurnee, IL), Codacovi; Lynn M. (Antioch, IL), Plattner; Jacob J. (Libertyville, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Filing Date:Mar 23, 1995
Application Number:08/409,391
Claims:1. A compound of the formula: ##STR525## or an acid addition salt thereof or an N-protected derivative thereof wherein at each occurrence the N-protecting group is independently selected from the group consisting of formyl, acetyl, pivaloyl, t-butylacetyl, t-butyloxycarbonyl, benzyloxycarbonyl, benzyl and isopropylaminocarbonyl.

2. A compound selected from the group consisting of:

2-(N-benzylamino)-5-(t-butyloxycarbonylamino)-3,4-dihydroxy-1,6-diphenylhex ane;

2-(N-benzyl-N-(benzyloxycarbonyl)amino)-5-(t-butyloxycarbonylamino)-3,4-dih ydroxy-1,6-diphenylhexane;

5-amino-2-(N-benzylamino)-3,4-dihydroxy-1,6-diphenylhexane;

2-amino-5-(t-butyloxycarbonylamino)-3,4-dihydroxy-1,6-diphenylhexane;

2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diphenylhexane;

(2S,3R,4R,5S)-2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diph enylhexane;

(2S,3S,4S,5S)-2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diph enylhexane;

(2S,3R,4S,5S)-2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diph enylhexane;

(2S,3R,4R,5S)-2,5-diamino-3,4-dihydroxy-1,6-diphenylhexane;

(2S,3S,4S,5S)-2,5-diamino-3,4-dihydroxy-1,6-diphenylhexane;

(2S,3R,4S,5S)-2,5-diamino-3,4-dihydroxy-1,6-diphenylhexane;

(2S,3S,4R,5S)-5-amino-2-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-d iphenylhexane; and

(2S,3R,4S,5S)-2,5-di-(N-((isopropylaminocarbonyl)amino)-3,4-dihydroxy-1,6-d iphenylhexane;

or an acid addition salt thereof.

3. A compound selected from the group consisting of:

(2S,3R,4R,5S)-2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diph enylhexane;

(2S,3S,4S,5S)-2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diph enylhexane; and

(2S,3R,4S,5S)-2,5-di-(N-((t-butyloxy)carbonyl)amino)-3,4-dihydroxy-1,6-diph enylhexane.

4. A compound selected from the group consisting of:

(2S,3R,4R,5S)-2,5-diamino-3,4-dihydroxy-1,6-diphenylhexane;

(2S,3S,4S,5S)-2,5-diamino-3,4-dihydroxy-1,6-diphenylhexane; and

(2S,3R,4S,5S)-2,5-diamino-3,4-dihydroxy-1,6-diphenylhexane;

or an acid addition salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc